A significant discovery in cancer research is emerging with the use of mini-antibodies to reactivate damaged p53. This crucial malignant inhibitor protein is frequently inactivated in various kinds of cancer, resulting https://mixbookmark.com/story7684833/mini-antibodies-revive-tumor-suppressor-p53-new-promising-hope-for-cancer-therapy